Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
Condition(s):Glaucoma; Ocular HypertensionLast Updated:March 16, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Glaucoma; Ocular HypertensionLast Updated:March 16, 2022Not yet recruiting
Condition(s):Intraocular Pressure (IOP); Tear Break-Up TimeLast Updated:April 18, 2012Unknown status
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:April 19, 2022Recruiting
Condition(s):VitiligoLast Updated:August 28, 2018Unknown status
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:April 27, 2022Recruiting
Condition(s):Non-segmental VitiligoLast Updated:March 23, 2021Active, not recruiting
Condition(s):Glaucoma; Ocular HypertensionLast Updated:February 8, 2021Completed
Condition(s):Glaucoma, Open-Angle; Hypertension, OcularLast Updated:September 24, 2020Completed
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:July 12, 2012Unknown status
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:December 11, 2014Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.